This is what the path from early-stage startup to national player looks like. As a two-time Alabama Launchpad winner, CerFlux shows how founder grit, academic partnerships and early-stage support add up over time. Milestones like this build momentum for the next wave of Alabama founders and the people backing them!! Congratulations, CerFlux + Karim Budhwani. We’re proud to have been part of your journey! #AlabamaLaunchpad #Biotech #InnovationEconomy
CerFlux, a Birmingham-based cancer biotechnology company, has received a $1.25 million award from the U.S. National Science Foundation to advance a collaborative cancer research program with the University of Virginia. The project will further develop CerFlux’s BEST™ platform, which is designed to create more predictive models for evaluating cancer therapies and improving drug-development decisions. By connecting cutting-edge research, entrepreneurial innovation and academic expertise, founders are moving transformative technologies from the lab toward meaningful outcomes for patients. Congratulations to the CerFlux team on this national recognition and important step forward in advancing cancer research. Read the full story in the comments.